Skip to the page

Data / Drug companies / AiPing Pharmaceutical, Inc.

AiPing Pharmaceutical, Inc.: 66 products in the FDA NDC directory, labeler code 11788

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

AiPing Pharmaceutical, Inc. (labeler code 11788) lists 66 products in the FDA National Drug Code Directory, covering 21 finished drugs by generic name. By type: 65 prescription drugs, 1 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 30, 2026.

The request: Watch AiPing Pharmaceutical, Inc. (FDA labeler code 11788): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
11788
Products in commercial distribution
66
Packages
127
Finished drugs by generic name
21
Prescription products
65
Over the counter products
1
Flagged as original packager
55 of 55 products that carry the flag
Started marketing in the last 12 months
48
Earliest marketing start
September 17, 1997
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)6598.5%
Over the counter monograph drugs11.5%

Products by type

TypeProductsShare
Prescription drugs6598.5%
Over the counter drugs11.5%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet4263.6%
Tablet, film coated69.1%
Capsule57.6%
Tablet, coated46.1%
Powder, for suspension34.5%
Tablet, extended release34.5%
Tablet, film coated, extended release23%
Tablet, chewable11.5%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Isosorbide Mononitrate11788-161Tablet, extended releaseGeneric drugs (ANDA)October 30, 2026
Isosorbide Mononitrate11788-160Tablet, extended releaseGeneric drugs (ANDA)October 30, 2026
Isosorbide Mononitrate11788-159Tablet, extended releaseGeneric drugs (ANDA)October 30, 2026
Cyclobenzaprine hydrochloride11788-095Tablet, film coatedGeneric drugs (ANDA)October 23, 2026
Cyclobenzaprine hydrochloride11788-094Tablet, film coatedGeneric drugs (ANDA)October 23, 2026
Cyclobenzaprine hydrochloride11788-093Tablet, film coatedGeneric drugs (ANDA)October 23, 2026
Glipizide11788-120TabletGeneric drugs (ANDA)October 9, 2026
Glipizide11788-118TabletGeneric drugs (ANDA)October 9, 2026
Glipizide11788-118TabletGeneric drugs (ANDA)October 9, 2026
Glipizide11788-117TabletGeneric drugs (ANDA)October 9, 2026
Glipizide11788-117TabletGeneric drugs (ANDA)October 9, 2026
Cholestyramine11788-150Powder, for suspensionGeneric drugs (ANDA)September 1, 2026
Ticagrelor11788-158TabletGeneric drugs (ANDA)June 10, 2026
Ticagrelor11788-157TabletGeneric drugs (ANDA)June 10, 2026
Haloperidol11788-076TabletGeneric drugs (ANDA)April 8, 2026
Haloperidol11788-075TabletGeneric drugs (ANDA)April 8, 2026
Haloperidol11788-074TabletGeneric drugs (ANDA)April 8, 2026
Haloperidol11788-073TabletGeneric drugs (ANDA)April 8, 2026
Haloperidol11788-072TabletGeneric drugs (ANDA)April 8, 2026
Haloperidol11788-071TabletGeneric drugs (ANDA)April 8, 2026
Captopril11788-138TabletGeneric drugs (ANDA)April 1, 2026
Captopril11788-137TabletGeneric drugs (ANDA)April 1, 2026
Captopril11788-136TabletGeneric drugs (ANDA)April 1, 2026
Captopril11788-135TabletGeneric drugs (ANDA)April 1, 2026
Methimazole11788-012TabletGeneric drugs (ANDA)April 1, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.